Back
Erie Indemnity Vs. ANI Pharmaceuticals Industry Stock Comparison
Buy
82
ERIE
Erie Indemnity
Last Price:
524.99
Seasonality Move:
1.67%
Buy
53
ANIP
ANI Pharmaceuticals
Last Price:
60.92
Seasonality Move:
0.29%
Buy
82
Erie Indemnity (ERIE)
is a Buy
Is Erie Indemnity a Buy, Sell or Hold?
- The current Erie Indemnity [ERIE] share price is $536.57. The Score for ERIE is 82, which is 64% above its historic median score of 50, and infers lower risk than normal.
- ERIE is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
Buy
53
ANI Pharmaceuticals (ANIP)
is a Buy
Is ANI Pharmaceuticals a Buy, Sell or Hold?
- The current ANI Pharmaceuticals [ANIP] share price is $61.05. The Score for ANIP is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
- ANIP is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
ERIE Stock Price Chart
What is Erie Indemnity's stock price today?
-
The Erie Indemnity share price today is $536.57
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ERIE is experiencing buying pressure, which is a positive indicator for future bullish movement.
ANIP Stock Price Chart
What is ANI Pharmaceuticals's stock price today?
-
The ANI Pharmaceuticals share price today is $61.05
The current trend is relatively stagnant and ANIP is experiencing slight selling pressure.
ERIE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 20.26 | Buy |
| Relative Strength Index (14 RSI): | 76.17 | Buy |
| Chaikin Money Flow: | 90469 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (477.35 - 515.11) | Buy |
| Bollinger Bands (100): | (359.52 - 468.62) | Buy |
ANIP Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.84 | Sell |
| Relative Strength Index (14 RSI): | 52.65 | Buy |
| Chaikin Money Flow: | -163397 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (57.84 - 62.92) | Buy |
| Bollinger Bands (100): | (59.73 - 65.45) | Sell |
ERIE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 516.56 | Buy |
| 20-day SMA: | 502.66 | Buy |
| 50-day SMA: | 453.29 | Buy |
| 200-day SMA: | 388.21 | Buy |
| 8-day EMA: | 519.36 | Buy |
| 20-day EMA: | 501.5 | Buy |
| 50-day EMA: | 464.49 | Buy |
| 200-day EMA: | 391.52 | Buy |
ANIP Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 57.54 | Buy |
| 20-day SMA: | 60.34 | Buy |
| 50-day SMA: | 61.2 | Sell |
| 200-day SMA: | 61.23 | Sell |
| 8-day EMA: | 58.88 | Buy |
| 20-day EMA: | 59.62 | Buy |
| 50-day EMA: | 60.85 | Buy |
| 200-day EMA: | 60.54 | Buy |
Erie Indemnity Earnings Growth & ERIE Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.93 per share, an increase next quarter of $0.81 per share, an increase this year of $2.75 per share, and an increase next year of $2.85 per share.
ANI Pharmaceuticals Earnings Growth & ANIP Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.25 per share, an increase next quarter of $0.40 per share, an increase this year of $0.29 per share, and an increase next year of $0.99 per share.
Erie Indemnity Technical Analysis
| Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
ANI Pharmaceuticals Technical Analysis
| Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||